Within the life settlement industry, the medical record review has long remained one of the most resource-intensive and time-consuming stages of the process. Even as other aspects of the industry have adopted data-driven solutions, this particular function continues to depend heavily on manual review. Underwriters are often tasked with sorting through thousands of pages of unstructured, inconsistent, and redundant medical information, an endeavor that can delay transactions, increase costs, and limit deal flow.
Recent advancements in automation and artificial intelligence, however, are beginning to change this dynamic. The ability to interpret and structure medical data with greater accuracy and speed is reshaping how the industry approaches one of its most persistent bottlenecks.
The Enduring Bottleneck
Medical records form the evidentiary basis of every life settlement transaction. They inform life expectancy estimates, guide underwriting decisions, and influence valuations. Yet the format and inconsistency of these records often make the review process cumbersome. A single case file can exceed 10,000 pages and include a combination of faxes, handwritten notes, lab results, and scanned reports, often from multiple providers.
Reviewers must identify relevant diagnoses, medications, and procedures buried within this mass of information. The process demands a high level of expertise but is inherently repetitive. For years, industry professionals have described it as a “needle-in-a-haystack” exercise that consumes valuable time and introduces unnecessary friction into the transaction lifecycle.
At its core, the challenge lies not in the quality of the underwriting itself but in the inefficiency of the information pipeline. Medical data is designed for patient care, not for investment evaluation. Converting that data into an accessible, structured format remains a major obstacle to efficiency.
The Rise of Automation
Automation has already transformed several document-intensive industries, including insurance claims, legal discovery, and mortgage processing. The life settlement sector now finds itself on the cusp of a similar transition.
At its essence, automation in medical record review involves the use of algorithms to extract and classify relevant data while filtering out extraneous content. These systems leverage a combination of optical character recognition, natural language processing, and medical ontologies to recognize terminology, identify relationships among conditions, and present structured summaries that underwriters can review directly.
Importantly, this technology is not a replacement for human expertise but a complement to it. Automated tools handle the labor-intensive elements—scanning, categorizing, and highlighting key data—so that human underwriters can focus on interpretation, risk assessment, and judgment. The result is not mechanization but augmentation.
Benefits Across the Transaction Chain
The adoption of automation yields benefits across every level of the life settlement value chain.
- Reduced review timelines: Automated systems can condense weeks of manual work into days, accelerating underwriting and enabling greater throughput.
- Enhanced accuracy: Machines do not tire or lose concentration, which helps maintain consistent standards across large record sets. They also improve error detection by cross-referencing terms and recognizing anomalies that might escape human attention.
- Lower operational costs: Streamlining review processes decreases administrative overhead and reallocates skilled labor toward higher-value tasks.
- Improved transparency and compliance: Structured, auditable data outputs make it easier to document what information informed a decision, strengthening both regulatory and investor confidence.
- Faster outcomes for policyowners: Shorter processing times mean policyowners receive offers sooner, improving the overall market experience.
Once medical data has been digitized and standardized, its value extends far beyond underwriting. Structured datasets enable richer analytics, predictive modeling, and performance benchmarking across portfolios. Investors and providers can analyze trends over time, while institutions can adopt more consistent valuation frameworks.
Implementation and Oversight
While the benefits of automation are clear, effective implementation requires thoughtful execution. Each organization in the life settlement ecosystem, whether a provider, broker, or institutional investor, has distinct operational workflows. Successful adoption therefore depends on integrating automation in ways that respect these variations rather than replacing existing infrastructure entirely.
Security remains paramount. Medical records contain some of the most sensitive categories of personal information, and their handling must meet the strictest standards of data protection and compliance, including HIPAA and SOC 2. Beyond compliance, there must also be careful attention to human oversight.
The most effective approaches employ a hybrid model in which technology handles the data extraction, classification, and organization, while human reviewers validate and interpret the output. This approach maintains accuracy while delivering significant gains in speed and consistency.
The Broader Outlook
As automation becomes more sophisticated, its impact on the life settlement industry will extend well beyond medical record review. Structured medical data could enable faster underwriting models, facilitate portfolio analytics, and support continuous monitoring of life expectancy assumptions.
In time, the same underlying technologies could allow for more dynamic risk assessment and greater liquidity in the secondary market. As standardized data becomes the norm, investors will be able to compare portfolios more effectively, reinsurers will assess exposure more accurately, and regulators will have greater clarity into underlying assumptions and practices.
These developments would represent a significant maturation of the asset class. What was once a largely manual, paper-based process could evolve into a transparent, data-driven marketplace.
Conclusion
The life settlement industry stands at an important inflection point. The fundamental challenge of managing unstructured medical data has persisted for decades, but the tools now exist to address it in a meaningful way. Automation and intelligent data processing are not theoretical improvements; they are practical, measurable solutions that can reshape the economics and efficiency of life settlements.
The firms that adopt these technologies early are likely to set new standards for speed, accuracy, and transparency. Ultimately, the ability to convert medical records into structured, decision-ready insights may determine which organizations lead the industry’s next phase of growth.
Dan Sobolewski is CEO at ProtectFlow
Any views expressed in this article are those of the author(s) and may not necessarily represent those of Longevity & Mortality Investor or its publisher, the European Life Settlement Association